Overview: Beta-Hydroxybutyrate TestIntroduction: The Beta-Hydroxybutyrate Test measures beta-hydroxybutyrate to diagnose diabetic ketoacidosis (DKA), causing nausea or fatigue. Aligned with 2023 ADA guidelines, it uses biochemical methods for high specificity, supporting diabetes screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected DKA.
Other Names: Ketone Body Assay, DKA Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Beta-hydroxybutyrate testing began in the 1980s with DKA research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures beta-hydroxybutyrate to diagnose DKA, guides treatment, and evaluates patients with nausea or fatigue.
Test Parameters: 1. Beta Hydroxybutyrate
Pretest Condition: Fasting 10-12 hours required. Collect serum or plasma. Report history of nausea, fatigue, or diabetes symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document nausea, fatigue, high blood sugar, or family history of diabetes. Include current medications, especially insulin.
Consent: Written consent required, detailing the tests purpose, DKA implications, and risks of blood collection.
Procedural Considerations: Uses biochemical methods to measure beta-hydroxybutyrate in serum or plasma. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for DKA diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Non-fasting samples may reduce accuracy.
Clinical Significance: Elevated beta-hydroxybutyrate confirms DKA, guiding insulin therapy and fluid replacement. Normal levels may require further metabolic testing.
Specialist Consultation: Consult an endocrinologist or emergency physician for result interpretation and treatment planning.
Additional Supporting Tests: Blood glucose, arterial blood gas, or urine ketones to confirm DKA diagnosis.
Test Limitations: Not specific to DKA; other ketogenic states may elevate levels. Clinical correlation is needed.
References: ADA Diabetes Guidelines, 2023; Diabetes Care, Kitabchi AE, 2022.
